Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study

Abstract Background Sclerostin, an antagonist of the Wingless-type mouse mammary tumor virus integration site (Wnt) pathway that regulates bone metabolism, is a potential contributor of chronic kidney disease (CKD)–mineral and bone disorder (MBD), which has various forms of presentation, from osteop...

Full description

Bibliographic Details
Main Authors: Te-Hui Kuo, Wei-Hung Lin, Jo-Yen Chao, An-Bang Wu, Chin-Chung Tseng, Yu-Tzu Chang, Hung-Hsiang Liou, Ming-Cheng Wang
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Nephrology
Subjects:
Sclerostin
Bone mineral density
Peritoneal dialysis
Chronic kidney disease–mineral and bone disorder (CKD–MBD)
Wnt pathway
Online Access:http://link.springer.com/article/10.1186/s12882-019-1452-5

Internet

http://link.springer.com/article/10.1186/s12882-019-1452-5

Similar Items